Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2009 1
2017 1
2018 2
2019 7
2020 6
2021 6
2022 9
2023 4

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Carbapenems in pediatrics.
Ayalew K, Nambiar S, Yasinskaya Y, Jantausch BA. Ayalew K, et al. Ther Drug Monit. 2003 Oct;25(5):593-9. doi: 10.1097/00007691-200310000-00009. Ther Drug Monit. 2003. PMID: 14508383 Review.
Use of PRO Measures to Inform Tolerability in Oncology Trials: Implications for Clinical Review, IND Safety Reporting, and Clinical Site Inspections.
Kim J, Singh H, Ayalew K, Borror K, Campbell M, Johnson LL, Karesh A, Khin NA, Less JR, Menikoff J, Minasian L, Mitchell SA, Papadopoulos EJ, Piekarz RL, Prohaska KA, Thompson S, Sridhara R, Pazdur R, Kluetz PG. Kim J, et al. Among authors: ayalew k. Clin Cancer Res. 2018 Apr 15;24(8):1780-1784. doi: 10.1158/1078-0432.CCR-17-2555. Epub 2017 Dec 13. Clin Cancer Res. 2018. PMID: 29237718 Review.
Challenges with Novel Clinical Trial Designs: Master Protocols.
Cecchini M, Rubin EH, Blumenthal GM, Ayalew K, Burris HA, Russell-Einhorn M, Dillon H, Lyerly HK, Reaman GH, Boerner S, LoRusso PM. Cecchini M, et al. Among authors: ayalew k. Clin Cancer Res. 2019 Apr 1;25(7):2049-2057. doi: 10.1158/1078-0432.CCR-18-3544. Epub 2019 Jan 29. Clin Cancer Res. 2019. PMID: 30696689
Resistance is common in paediatric patients failing ART in South Africa.
Hunt GM, Yousif M, Levin L, Ledwaba J, Steegen K, Kufa T, Zwane H, Kalimashe M, Kana V, Aynalem G, Perlman J, Ayalew K, Kindra G, Diallo K, Carmona S, Sherman G, Raizes EJ. Hunt GM, et al. Among authors: ayalew k. J Antimicrob Chemother. 2023 May 3;78(5):1160-1167. doi: 10.1093/jac/dkac443. J Antimicrob Chemother. 2023. PMID: 37017009 Free PMC article.
Moderate-to-High Levels of Pretreatment HIV Drug Resistance in KwaZulu-Natal Province, South Africa.
Chimukangara B, Kharsany ABM, Lessells RJ, Naidoo K, Rhee SY, Manasa J, Gräf T, Lewis L, Cawood C, Khanyile D, Diallo K, Ayalew KA, Shafer RW, Hunt G, Pillay D, Abdool SK, de Oliveira T. Chimukangara B, et al. Among authors: ayalew ka. AIDS Res Hum Retroviruses. 2019 Feb;35(2):129-138. doi: 10.1089/AID.2018.0202. Epub 2019 Jan 7. AIDS Res Hum Retroviruses. 2019. PMID: 30430843 Free PMC article.
Association between viral suppression during the third trimester of pregnancy and unintended pregnancy among women on antiretroviral therapy: Results from the 2019 antenatal HIV Sentinel Survey, South Africa.
Woldesenbet S, Kufa T, Manda S, Ayalew K, Lombard C, Cheyip M, Puren A. Woldesenbet S, et al. Among authors: ayalew k. PLoS One. 2022 Mar 17;17(3):e0265124. doi: 10.1371/journal.pone.0265124. eCollection 2022. PLoS One. 2022. PMID: 35298503 Free PMC article.
Is There Risk Compensation among HIV Infected Youth and Adults 15 Years and Older on Antiretroviral Treatment in South Africa? Findings from the 2017 National HIV Prevalence, Incidence, Behaviour and Communication Survey.
Zungu N, Mabaso M, Ramlagan S, Simbayi L, Moyo S, Shisana O, Murangandi P, Igumbor E, Sigida S, Jooste S, Marinda E, Ayalew K, Zuma K. Zungu N, et al. Among authors: ayalew k. Int J Environ Res Public Health. 2022 May 18;19(10):6156. doi: 10.3390/ijerph19106156. Int J Environ Res Public Health. 2022. PMID: 35627693 Free PMC article.
33 results